Alexander Ford's most recent trade in Myriad Genetics, Inc. was a trade of 6,653 Common Stock done at an average price of $13.0 . Disclosure was reported to the exchange on Sept. 30, 2020.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Myriad Genetics, Inc. | Alexander Ford | Chief Operating Officer | Sale or transfer of securities back to the company at price $ 13.04 per share. | 30 Sep 2020 | 6,653 | 169,040 (0%) | 0% | 13.0 | 86,755 | Common Stock |
Myriad Genetics, Inc. | Alexander Ford | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Sep 2020 | 41,000 | 192,159 (0%) | 0% | 0 | Common Stock | |
Myriad Genetics, Inc. | Alexander Ford | Chief Operating Officer | Sale or transfer of securities back to the company at price $ 12.44 per share. | 24 Sep 2020 | 6,653 | 185,506 (0%) | 0% | 12.4 | 82,763 | Common Stock |
Myriad Genetics, Inc. | Alexander Ford | Chief Operating Officer | Sale or transfer of securities back to the company at price $ 12.44 per share. | 24 Sep 2020 | 5,267 | 180,239 (0%) | 0% | 12.4 | 65,521 | Common Stock |
Myriad Genetics, Inc. | Alexander Ford | Chief Operating Officer | Sale or transfer of securities back to the company at price $ 12.44 per share. | 24 Sep 2020 | 4,546 | 175,693 (0%) | 0% | 12.4 | 56,552 | Common Stock |
Myriad Genetics, Inc. | Alexander Ford | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 13.78 per share. | 15 Sep 2020 | 2,804 | 151,159 (0%) | 0% | 13.8 | 38,630 | Common Stock |
Myriad Genetics, Inc. | Alexander Ford | President, MWH | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2020 | 11,525 | 153,963 (0%) | 0% | 0 | Common Stock |